Skip to Main Content

Try STAT+ TODAY

clinical trials

Most Read

Biotech Kate Sheridan

When biotech acquisitions spike, early-stage startups are prime targets, analysis shows

First Opinion Podcast Patrick Skerrett

Listen: Pharma companies market their drugs to young adults — so why don’t they include them in clinical trials?

Matt's Take Matthew Herper

New Covid trial results may point toward better ways to study medicines

Pharmalot Ed Silverman

Insufficient progress is being made in reporting clinical trial results in the U.S.

Health Tech Erin Brodwin and Casey Ross

Inside Verily’s make-or-break push to turn its most promising ideas into profits

Health Tech Katie Palmer

‘Some very noble, some less than noble’: The growing health data marketplace sparks privacy concerns

First Opinion Jennifer Goldsack, Rachel A. Chasse and William A. Wood

Digital endpoints library can aid clinical trials for new medicines

First Opinion Jennifer Goldsack

Synthetic control arms can save time and money in clinical trials

All Coverage

Heavyweights Angus Chen

The trust-builder: a cancer center director’s try-it-all strategy for breaking the barriers between research and Black patients

Pharmalot Ed Silverman

Major European research funders often fail to set policies or monitor progress on clinical trial transparency

advertisement

Health Tech Mario Aguilar

Drawing on therapy developed to save soldiers, an app aims to prevent suicide in those at highest risk

Health Tech Mario Aguilar and Mohana Ravindranath

Remote technology could nudge patients to join cancer clinical trials

Special Report Angus Chen

This clinical trial wanted to end breast cancer disparities. But first it needed to enroll Black women

Pharmalot Ed Silverman

The World Health Assembly moves to bolster clinical trials, but some say it falls short

Pharmalot Ed Silverman

Race is often overlooked in key clinical trial data used to win new drug approvals in Europe

Pharmalot Ed Silverman

In the wake of Covid, a World Health Assembly proposal would bolster quality of clinical trials

Pharmalot Ed Silverman

‘Harmful and wasteful’: Many pediatric clinical trials end early and don’t report results

Health Tech Matthew Herper

Virtual Event: Taking the pulse of clinical trials

Pharmalot Ed Silverman

Political pressure in the U.K. prompted more universities to report clinical trial results

Pharmalot Ed Silverman

No more waffling: Belgium discloses penalties for failing to report clinical trial results

Pharmalot Ed Silverman

Trial by fire: More study protocols are experiencing substantial — and costly — changes

Matt's Take Matthew Herper

Robert Califf is a fervent believer in data. At the FDA, will that be enough?

Health Tech Katie Palmer

Verily shakes up its leadership team, with a new president and a shift for CEO Conrad

The Pharmalot View Ed Silverman

Take a deep breath: Asthma drug study failed to include Black and Puerto Rican children who could benefit most

Pharmalot Ed Silverman

When FDA rattles its sabre, drug makers and universities start reporting overdue trial results

Pharmalot Ed Silverman

FDA warns a hospital and two physicians for putting patients at ‘significantly increased’ risk in trials

Pharmalot Ed Silverman

Pulling back the curtain: U.K. to launch new system for registering clinical trials automatically

Pharmalot Ed Silverman

MD Anderson hit with ethics complaint over failure to disclose clinical trial results

Pharmalot Ed Silverman

Europe’s largest clinical trial sponsors are getting better at reporting results

Pharmalot Ed Silverman

FDA tells drug makers to redo studies run by two contract research firms due to data integrity issues

Pharmalot Ed Silverman

U.K. government launches a new system to monitor clinical trial reporting

Pharmalot Ed Silverman

Biogen trials for Alzheimer’s drug excluded much of the targeted patient pool, study finds

Pharmalot Ed Silverman

For the first time, the FDA warns a trial investigator for failing to report study results